PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of brmedjLink to Publisher's site
 
Br Med J. 1971 March 6; 1(5748): 523–527.
PMCID: PMC1795296

Associations between Drugs Administered during Pregnancy and Congenital Abnormalities of the Fetus

Abstract

In a retrospective study to compare the drug consumption during pregnancy of mothers of infants with congenital abnormalities and of those without, over 97% of 1,369 mothers took prescribed drugs and 65% self-administered drugs. Significantly more mothers of infants with congenital abnormalities took aspirin, antacids, dextroamphetamine, phenobarbitone, sodium amytal, other barbiturates, cough medicines, iron, sulphonamides, and nicotinamide than mothers in the control group. However, most mothers taking analgesics, antacids, appetite suppressants, barbiturates, cough medicines, iron, sulphonamides, and vitamins produced normal infants. Any teratogenic effect of these drugs is therefore one of low potency. On the other hand, deficiencies such as those of ascorbic acid and folic acid may have a teratogenic effect. There is need for caution in presuming teratogenic effects on the basis of the associations shown here. During pregnancy, however, it would appear wise to avoid the administration of any drug which carries a suspicion of teratogenicity unless that drug is specifically indicated, and self-medication with common household remedies such as aspirin and antacids should be avoided. These recommendations would also apply to any woman of childbearing age in whom conception is likely.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.1M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Crombie DL, Pinsent RJ, Slater BC, Fleming D, Cross KW. Teratogenic drugs--R.C.G.P. survey. Br Med J. 1970 Oct 17;4(5728):178–179. [PMC free article] [PubMed]
  • Lenz W. Malformations caused by drugs in pregnancy. Am J Dis Child. 1966 Aug;112(2):99–106. [PubMed]
  • Mackler B. Studies of the molecular basis of congenital malformations. Pediatrics. 1969 Jun;43(6):915–926. [PubMed]
  • Meadow SR. Congenital abnormalities and anticonvulsant drugs. Proc R Soc Med. 1970 Jan;63(1):48–49. [PubMed]
  • Milunsky A, Graef JW, Gaynor MF., Jr Methotrexate-induced congenital malformations. J Pediatr. 1968 Jun;72(6):790–795. [PubMed]
  • Nelson MM, Forfar JO. Congenital abnormalities at birth: their association in the same patient. Dev Med Child Neurol. 1969 Feb;11(1):3–16. [PubMed]
  • Nishimura H, Takano K, Tanimura T, Yasuda M, Uchida T. High incidence of several malformations in the early human embryos as compared with infants. Biol Neonat. 1966;10(1):93–107. [PubMed]
  • Nora JJ, Nora AH, Sommerville RJ, Hill RM, McNamara DG. Maternal exposure to potential teratogens. JAMA. 1967 Dec 18;202(12):1065–1069. [PubMed]
  • Richards ID. Congenital malformations and environmental influences in pregnancy. Br J Prev Soc Med. 1969 Nov;23(4):218–225. [PMC free article] [PubMed]
  • TATTERSALL R. BARBITURATE TOXICITY. Practitioner. 1965 Jan;194:68–71. [PubMed]
  • TRASLER DG. ASPIRIN-INDUCED CLEFT LIP AND OTHER MALFORMATIONS IN MICE. Lancet. 1965 Mar 13;1(7385):606–607. [PubMed]
  • WARKANY J, TAKACS E. Experimental production of congenital malformations in rats by salicylate poisoning. Am J Pathol. 1959 Mar-Apr;35(2):315–331. [PubMed]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group